Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ionis Pharmaceuticals, Inc. - Common Stock (NQ:IONS)

70.42 -3.12 (-4.25%)
Streaming Delayed Price Updated: 2:03 PM EST, Nov 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,784,301
Open 70.05
Bid (Size) 70.37 (300)
Ask (Size) 70.49 (100)
Prev. Close 73.55
Today's Range 66.66 - 71.49
52wk Range 23.95 - 76.78
Shares Outstanding 141,797,854
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Ionis Reports Substantial Drop In Acute Pancreatitis Events With Cholesterol Lowering Drug
Ionis' olezarsen cut triglycerides by up to 72% and reduced acute pancreatitis events by 85% in Phase 3 studies of severe hypertriglyceridemia. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga

Performance

YTD
+103.0%
+103.0%
1 Month
+0.7%
+0.7%
3 Month
+72.4%
+72.4%
6 Month
+110.0%
+110.0%
1 Year
+81.1%
+81.1%

More News

Read More
Monday.Com, Metsera, Profrac Holding And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Why Viasat Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Earnings Scheduled For October 29, 2025
Via Benzinga
Ionis Pharmaceuticals Earnings Preview
Via Benzinga
Groundbreaking pivotal study results of olezarsen for severe hypertriglyceridemia (sHTG) presented as a late breaker at AHA Scientific Sessions
From Ionis Pharmaceuticals, Inc.
Via Business Wire
Intellia Therapeutics Crashes After A Patient In Its Pivotal Study Dies
Via Investor's Business Daily
Topics Death
Ionis presents new data demonstrating long-term disease control with DAWNZERA™ (donidalorsen) at ACAAI 2025 Annual Meeting
From Ionis Pharmaceuticals, Inc.
Via Business Wire
Cathie Wood Goes All-In On Peter Thiel's Crypto Play Bullish With Back-To-Back Million-Dollar Buys
Via Benzinga
Ionis (IONS) Q3 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Alnylam Stock Has Already Doubled In 2025. Why It Could Rocket Again On Earnings.
Via Investor's Business Daily
Alphabet To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
Ionis reports third quarter 2025 financial results and highlights progress on key programs
From Ionis Pharmaceuticals, Inc.
Via Business Wire
Detailed data from the landmark CORE and CORE2 pivotal studies of olezarsen for sHTG to be presented as a late breaker at AHA Scientific Sessions
From Ionis Pharmaceuticals, Inc.
Via Business Wire
Ionis ranked #2 Top Employer by Science magazine, recognizing industry-leading scientific innovation and company culture
From Ionis Pharmaceuticals, Inc.
Via Business Wire
Ionis CEO Brett P. Monia receives 2025 Lifetime Achievement Award from the Oligonucleotide Therapeutics Society
From Ionis Pharmaceuticals, Inc.
Via Business Wire
Capricorn Buys New Stake in Ionis Pharmaceuticals (IONS) With 163,000 Shares
Via The Motley Fool
31 Analysts Assess Ionis Pharmaceuticals: What You Need To Know
Via Benzinga
Ionis to hold third quarter 2025 financial results webcast
From Ionis Pharmaceuticals, Inc.
Via Business Wire
IONIS PHARMACEUTICALS INC (NASDAQ:IONS) Shows Strong Growth Momentum and Technical Strength
Via Chartmill
Ionis Pharmaceuticals (NASDAQ:IONS) Ascends to Six-Year High, Fueled by Breakthrough Pipeline and Robust Sales Outlook
Via MarketMinute
Why Ionis Stock, Approaching A Six-Year High, Just Snagged A Price-Target Hike
Via Investor's Business Daily
This Penumbra Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday
Via Benzinga
Ionis showcases transformational medicines and industry-leading pipeline at Innovation Day
From Ionis Pharmaceuticals, Inc.
Via Business Wire

Frequently Asked Questions

Is Ionis Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Ionis Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Ionis Pharmaceuticals, Inc. - Common Stock trade on?
Ionis Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Ionis Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Ionis Pharmaceuticals, Inc. - Common Stock is IONS on the Nasdaq Stock Market
What is the current price of Ionis Pharmaceuticals, Inc. - Common Stock?
The current price of Ionis Pharmaceuticals, Inc. - Common Stock is 70.42
When was Ionis Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Ionis Pharmaceuticals, Inc. - Common Stock was at 11/10/25 02:03 PM ET
What is the market capitalization of Ionis Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Ionis Pharmaceuticals, Inc. - Common Stock is 9.99B
How many shares of Ionis Pharmaceuticals, Inc. - Common Stock are outstanding?
Ionis Pharmaceuticals, Inc. - Common Stock has 10B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.